Cite
HARVARD Citation
Hollifield, A. et al. (2020). Caplacizumab: an anti–von Willebrand factor antibody for the treatment of thrombotic thrombocytopenic purpura. American journal of health-system pharmacy. pp. 1201-1207. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hollifield, A. et al. (2020). Caplacizumab: an anti–von Willebrand factor antibody for the treatment of thrombotic thrombocytopenic purpura. American journal of health-system pharmacy. pp. 1201-1207. [Online].